Skip to main content Accessibility help
×
Home

Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain

  • Yasuhiro Suzuki (a1), Qila Sa (a1), Marie Gehman (a1) and Eri Ochiai (a1)

Abstract

Toxoplasma gondii is an obligate intracellular protozoan parasite that causes various diseases, including lymphadenitis, congenital infection of fetuses and life-threatening toxoplasmic encephalitis in immunocompromised individuals. Interferon-gamma (IFN-γ)-mediated immune responses are essential for controlling tachyzoite proliferation during both acute acquired infection and reactivation of infection in the brain. Both CD4+ and CD8+ T cells produce this cytokine in response to infection, although the latter has more potent protective activity. IFN-γ can activate microglia, astrocytes and macrophages, and these activated cells control the proliferation of tachyzoites using different molecules, depending on cell type and host species. IFN-γ also has a crucial role in the recruitment of T cells into the brain after infection by inducing expression of the adhesion molecule VCAM-1 on cerebrovascular endothelial cells, and chemokines such as CXCL9, CXCL10 and CCL5. A recent study showed that CD8+ T cells are able to remove T. gondii cysts, which represent the stage of the parasite in chronic infection, from the brain through their perforin-mediated activity. Thus, the resistance to cerebral infection with T. gondii requires a coordinated network using both IFN-γ- and perforin-mediated immune responses. Elucidating how these two protective mechanisms function and collaborate in the brain against T. gondii will be crucial in developing a new method to prevent and eradicate this parasitic infection.

Copyright

Corresponding author

*Corresponding author: Yasuhiro Suzuki, Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA. E-mail: yasu.suzuki@uky.edu

References

Hide All
1McCabe, R.E. and Remington, J.S. (1990) Toxoplasma gondii. In Principles and Practice of Infectious Diseases (Mandell, G.L., Douglas, R.G. and Bennett, J.E., eds), 2090, Churchill Livingstone Inc., New York
2Suzuki, Y. et al. (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240, 516-518
3Denkers, E.Y. and Gazzinelli, R.T. (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11, 569-588
4Boyer, K., Marcinak, J. and McLeod, R. (2007) Toxoplasma gondii (Toxoplasmosis). In Principles and Practice of Pediatric Infectious Diseases (3rd edn) (Long, S., Pickering, L.K. and Prober, C.G., eds), pp. 12671288, Churchill Livingstone, New York
5Israelski, D.M. and Remington, J.S. (1993) Toxoplasmosis in the non-AIDS immunocompromised host. In Current Clinical Topics in Infectious Diseases (Remington, J. S. and Swrltz, M. eds), pp. 322-356, Blackwell Scientific Publications, London
6Wong, S.Y. and Remington, J.S. (1994) Toxoplasmosis in the setting of AIDS. In Text Book of AIDS Medicine (Broder, S., Mergan, T. C. Jr. and Bolognesi, D., eds), pp. 223-257, Williams & Wikins, Baltimore
7Yazar, S. et al. (2003) Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure 12, 107-109
8Stommel, E.W. et al. (2001) Cryptogenic epilepsy: an infectious etiology? Epilepsia 42, 436-438
9Torrey, E.F. et al. (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 33, 729-736
10Wang, H.L. et al. (2006) Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatrica Scandinavica 114, 40-48
11Singh, J. et al. (2010) Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection. Microbes and Infection 12, 1252-1257
12Suzuki, Y. et al. (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. American Journal of Pathology 176, 1607-1613
13Courret, N. et al. (2006) CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107, 309-316
14Da Gama, L.M. et al. (2004) Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii. Microbes and Infection 6, 1287-1296
15Lambert, H. et al. (2006) Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cellular Microbiology 8, 1611-1623
16Barragan, A., Brossier, F. and Sibley, L.D. (2005) Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cellular Microbiology 7, 561-568
17Schluter, D. et al. (1995) Different subsets of T cells in conjunction with natural killer cells, macrophages, and activated microglia participate in the intracerebral immune response to Toxoplasma gondii in athymic nude and immunocompetent rats. American Journal of Pathology 146, 999-1007
18Suzuki, Y. et al. (1997) Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infection and Immunity 65, 2339-2345
19Hunter, C.A. et al. (1994) Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. Journal of Infectious Diseases 170, 939-945
20Suzuki, Y. et al. (1994) MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice. Journal of Immunology 153, 4649-4654
21Brown, C.R. et al. (1995) Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85, 419-428
22Wang, X. et al. (2004) Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infection and Immunity 72, 4432-4438
23Wang, X. et al. (2005) Importance of CD8(+)Vbeta8(+) T Cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. Journal of Interferon and Cytokine Research 25, 338-344
24Kang, H. et al. (2003) TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Journal of Immunology 170, 4254-4259
25Lutjen, S. et al. (2006) Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4T cells. Infection and Immunity 74, 5790-5801
26Hochrein, H. et al. (2000) Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. Journal of Experimental Medicine 192, 823-833
27Yap, G., Pesin, M. and Sher, A. (2000) Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. Journal of Immunology 165, 628-631
28Jin, D. et al. (2009) STAT6 signalling is important in CD8 T-cell activation and defence against Toxoplasma gondii infection in the brain. Immunology 127, 187-195
29Kang, H. and Suzuki, Y. (2001) Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infection and Immunity 69, 2920-2927
30Schaeffer, E.M. et al. (1999) Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284, 638-641
31Nishanth, G. et al. (2010) Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta. Infection and Immunity 78, 3454-3464
32LaRosa, D.F. et al. (2008) T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proceedings of the National Academy of Sciences of the United States of America 105, 3855-3860
33Caamano, J. et al. (2000) Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. Journal of Immunology 165, 5720-5728
34Mason, N.J., Liou, H.C. and Hunter, C.A. (2004) T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. Journal of Immunology 172, 3704-3711
35Caamano, J. et al. (1999) The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. Journal of Immunology 163, 4453-4461
36Harris, T.H. et al. (2010) NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS. Journal of Neuroimmunology 222, 19-28
37Blanchard, N. et al. (2008) Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 9, 937-944
38Caetano, B.C. et al. (2006) Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Human Gene Therapy 17, 415-426
39Frickel, E.M. et al. (2008) Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. Journal of Infectious Diseases 198, 1625-1633
40Kirak, O. et al. (2010) Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 328, 243-248
41Wilson, D.C. et al. (2010) Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathogens 6, e1000815
42Cong, H. et al. (2010) Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine 29, 754-762
43Cong, H. et al. (2010) Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8 + T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii. Immunome Research 6, 12
44Tan, T.G. et al. (2010) Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 28, 3977-3989
45Cong, H. et al. (2010) Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8 + T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii. Immunome Research 6, 12
46Schaeffer, M. et al. (2009) Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. Journal of Immunology 182, 6379-6393
47Wilson, E.H. et al. (2009) Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 30, 300-311
48Suzuki, Y. et al. (2005) Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. International Journal of Parasitology 35, 83-90
49Wang, X. and Suzuki, Y. (2007) Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. Journal of Interferon and Cytokine Research 27, 599-605
50De Simone, R., Levi, G. and Aloisi, F. (1998) Interferon gamma gene expression in rat central nervous system glial cells. Cytokine 10, 418-422
51Lindberg, C. et al. (2005) Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. Journal of Molecular Neuroscience 27, 1-12
52Kawanokuchi, J. et al. (2006) Production of interferon-gamma by microglia. Multiple Sclerosis 12, 558-564
53Cannella, B. and Raine, C.S. (2004) Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Annals of Neurology 55, 46-57
54Chao, C.C. et al. (1994) Human microglial cell defense against Toxoplasma gondii. The role of cytokines. Journal of Immunology 152, 1246-1252
55Chao, C.C. et al. (1993) Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. Journal of Immunology 150, 3404-3410
56Chao, C.C. et al. (1993) Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clinical Immunology and Immunopathology 67, 178-183
57Freund, Y.R., Zaveri, N.T. and Javitz, H.S. (2001) In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice. Infection and Immunity 69, 765-772
58Deckert-Schluter, M. et al. (1999) Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. American Journal of Pathology 154, 1549-1561
59Deckert-Schluter, M. et al. (1995) Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice. Immunology 85, 408-418
60Hunter, C.A., Roberts, C.W. and Alexander, J. (1992) Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. European Journal of Immunology 22, 2317-2322
61Fischer, H.G. et al. (1993) Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. Journal of Neuroimmunology 45, 193-201
62Deckert, M. et al. (2006) Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathologica 111, 548-558
63Portillo, J.A. et al. (2010) The CD40-autophagy pathway is needed for host protection despite IFN-Gamma-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 5, e14472
64Peterson, P.K. et al. (1995) Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. Journal of Infectious Diseases 171, 516-518
65Pelloux, H. et al. (1996) Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells. Parasitology Research 82, 598-603
66Daubener, W. et al. (1996) Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. European Journal of Immunology 26, 487-492
67Halonen, S.K., Chiu, F. and Weiss, L.M. (1998) Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infection and Immunity 66, 4989-4993
68Halonen, S.K., Taylor, G.A. and Weiss, L.M. (2001) Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infection and Immunity 69, 5573-5576
69Martens, S. et al. (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathogens 1, e24
70Melzer, T. et al. (2008) The gamma interferon (IFN-gamma)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-gamma-stimulated astrocytes. Infection and Immunity 76, 4883-4894
71Drogemuller, K. et al. (2008) Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. Journal of Immunology 181, 2683-2693
72Schluter, D. et al. (1998) Interferon-gamma antagonizes transforming growth factor-beta2-mediated immunosuppression in murine Toxoplasma encephalitis. Journal of Neuroimmunology 81, 38-48
73Wilson, E.H. et al. (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Journal of Neuroimmunology 165, 63-74
74Adams, L.B. et al. (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. Journal of Immunology 144, 2725-2729
75Butcher, B.A. et al. (2005) p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infection and Immunity 73, 3278-3286
76Ling, Y.M. et al. (2006) Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. Journal of Experimental Medicine 203, 2063-2071
77Zhao, Z. et al. (2008) Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host and Microbe 4, 458-469
78Lees, M.P. et al. (2010) P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. Journal of Immunology 184, 7040-7046
79Jamieson, S.E. et al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes and Immunity 11, 374-383
80Wang, X. et al. (2007) Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii. Journal of Interferon and Cytokine Research 27, 329-338
81Deckert, M. et al. (2003) Mice with neonatally induced inactivation of the vascular cell adhesion molecule-1 fail to control the parasite in Toxoplasma encephalitis. European Journal of Immunology 33, 1418-1428
82Amichay, D. et al. (1996) Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. Journal of Immunology 157, 4511-4520
83Strack, A. et al. (2002) Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathologica (Berlin) 103, 458-468
84Wen, X. et al. (2010) Predominant interferon-gamma-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis. Journal of Interferon and Cytokine Research 30, 653-660
85Strack, A. et al. (2002) Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors. Glia 40, 372-377
86Park, M.K. et al. (2002) The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. Journal of Immunology 169, 1433-1443
87Sallusto, F. et al. (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. Journal of Experimental Medicine 187, 875-883
88Moser, B. and Loetscher, P. (2001) Lymphocyte traffic control by chemokines. Nature Immunology 2, 123-128
89Khan, I.A. et al. (2000) IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12, 483-494
90Benevides, L. et al. (2008) CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. American Journal of Pathology 173, 741-751
91Clark, R.T. et al. (2011) T-cell production of matrix metalloproteinase and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain. ASN Neuro 3, e00049.
92Gazzinelli, R.T. et al. (1994) Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. Journal of Immunology 153, 2533-2543
93Yarovinsky, F. et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626-1629
94Scanga, C.A. et al. (2002) Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. Journal of Immunology 168, 5997-6001
95Cai, G. et al. (2000) Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. Journal of Immunology 165, 2619-2627
96Watford, W.T. et al. (2008) Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii. Journal of Experimental Medicine 205, 2803-2812
97Aliberti, J., Serhan, C. and Sher, A. (2002) Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. Journal of Experimental Medicine 196, 1253-1262
98Machado, F.S. et al. (2006) Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature Medicine 12, 330-334
99Suzuki, Y. et al. (1996) IL-4 is protective against development of toxoplasmic encephalitis. Journal of Immunology 157, 2564-2569
100Roberts, C.W. et al. (1996) Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infection and Immunity 64, 897-904
101Kuhn, R. et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274
102Gazzinelli, R.T. et al. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of Immunology 157, 798-805
103Suzuki, Y. et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. Journal of Immunology 164, 5375-5382
104Jankovic, D. et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. Journal of Experimental Medicine 204, 273-283
105Shaw, M.H. et al. (2006) Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. Journal of Immunology 176, 7263-7271
106Kelly, M.N. et al. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infection and Immunity 73, 617-621
107Stumhofer, J.S. et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunology 7, 937-945
108Jones, L.A. et al. (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. European Journal of Immunology 40, 426-436
109Denkers, E.Y. et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. Journal of Immunology 159, 1903-1908
110Yamashita, K. et al. (1998) Cytotoxic T-lymphocyte-mediated lysis of Toxoplasma gondii-infected target cells does not lead to death of intracellular parasites. Infection and Immunity 66, 4651-4655
111Ferguson, D.J. and Hutchison, W.M. (1987) An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice. Parasitology Research 73, 483-491
112Ghatak, N.R. and Zimmerman, H.M. (1973) Fine structure of Toxoplasma in the human brain. Archives of Pathology 95, 276-283
Yarovinsky, F. (2008) Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunology Letters 119, 17-21
This article provides an overview on the role of TLRs in resistance to T. gondii infection.
Munoz, M., Liesenfeld, O. and Heimesaat, M.M. (2011) Immunology of Toxoplasma gondii. Immunology Reviews 240, 269-285.
This article provides an overview of the immune responses to T. gondii in general, including immune responses in the intestine and those in congenital and ocular toxoplasmosis.
The Toxoplasma gondii database is a genome and functional genomic database in which sequence information is integrated with various genomic-scale data, including community annotation, ESTs, gene expression and proteomics data:http://toxodb.org/toxo/

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed